GLP-1 RAs are associated with a modestly increased risk for GERD and gallstone disease but not with GI and biliary complications.

Exercise-based cardiac rehabilitation (ExCR) shows clinical benefits in patients with atrial fibrillation (AF), according to a review published online.

Treatments for acromegaly, edema, HSCT-associated thrombotic microangiopathy, multiple sclerosis, and spinal muscular atrophy are under review.

Vitamin D insufficiency and deficiency are tied to higher risk of being hospitalized for COVID-19, according to a study published online.

SURPASS-CVOT evaluated the efficacy and safety of tirzepatide compared with dulaglutide in adults with T2D and a confirmed ASCVD.

Polygenic scores (PGSs) for body mass index (BMI) can improve obesity prediction, according to a study published online.

Three of the most widely studied healthy dietary patterns are associated with lower incidence of type 2 diabetes (T2D), regardless of an individual's ethnicity.

The FDA has approved a labeling update for Leqvio (inclisiran) allowing for first-line use in the treatment of hypercholesterolemia.

Relatives bereaved by natural death with high and sustained grief symptoms have increased mental health care use and mortality for up to 10 years after the loss.

The FDA has granted clearance for the CardioTag device to assess cardiac function and improve patient outcomes across various healthcare settings.

In patients with diabetic wounds, copper oxide impregnated dressings were noninferior to standard negative pressure wound therapy.

Sarilumab and tocilizumab are equally effective in reducing organ support duration and death in patients who are critically ill with COVID-19.